Brief: Ac Immune’S Aci-35.030 (Now “JNJ-2056”) Granted FDA Fast Track Designation For Alzheimer’S Disease
25/07/2024 12:23
July 25 (Reuters) - AC Immune SA ACIU.O :
* AC IMMUNE’S ACI-35.030 (NOW “JNJ-2056”) GRANTED FDA FAST
TRACK
DESIGNATION FOR ALZHEIMER’S DISEASE
Source text for Eikon: ID:nGNX9p99cl
Further company coverage: ACIU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture